Predict your next investment

RISK & SECURITY | Security Services
ia911.com

See what CB Insights has to offer

Founded Year

2003

Stage

Other Investors | Alive

About InfrAegis

InfrAegis, Inc. will continue to brand and market the company as IA. IA's focal platforms will become global leaders in 21st century standards in national security and biodefense. IA is actively pursuing proposals and responses for a number of iaMedium applications including, but not limited to: real estate / shopping malls in Southeast Asia, the metropolitan transit system for a U.S. East Coast city, and a railway system in Asia.

InfrAegis Headquarter Location

1612 Landmeier Road Suite F

Elk Grove Village, Illinois, 60007,

United States

Latest InfrAegis News

Elk Grove CEO charged with defrauding investors of $9 million

Feb 28, 2014

Article updated: 2/28/2014 12:06 PM Elk Grove CEO charged with defrauding investors of $9 million Article By Anna Marie Kukec More than 200 investors in a company with an Elk Grove Village office that claimed to make Homeland Security and food safety products lost more than $9 million through the offer and sale of stock, according to a federal fraud indictment against the company’s chief executive officer. Gregory Webb, chairman, CEO, president and majority shareholder of InfrAegis Inc ., was charged with eight counts of mail fraud and three counts of wire fraud in an 11-count indictment returned by a federal grand jury on Thursday, the U.S. attorney’s office said Friday. Advertisement Webb, 68, of Dallas and formerly of Arlington Heights, will be arraigned on a date to be determined in U.S. District Court in Chicago. He formed InfrAegis in 2003 under the name Intelagents, Inc., and changed its name to InfrAegis in 2005. Messages left at his offices were not immediately returned. The indictment also seeks forfeiture of more than $9 million in alleged fraudulent proceeds, documents said. Each count of mail and wire fraud carries a maximum penalty of 20 years in prison and a $250,000 fine, and restitution is mandatory if Webb is convicted. The U.S. Securities and Exchange Commission also filed a civil case against Webb and InfrAegis in 2011 in federal court in Chicago. The company lists its corporate office in Washington, D.C., and other offices in Elk Grove Village, Chicago and Carlsbad, Calif. According to the indictment, between 2007 and October 2013, Webb and InfrAegis obtained more than $9 million from investors through offering and selling stock in the company by making false representations about the solvency and financial condition of InfrAegis, the contracts that it expected to be awarded or had been awarded, and the expected and actual returns on investments in the company. Webb allegedly knew that stock-offering materials falsely portrayed InfrAegis as a financially successful company that had both high-level connections in the Homeland Security market and lucrative contracts for the sale of its products, documents said. Webb and InfrAegis falsely represented in written materials and investor conference calls that the city of Chicago had agreed to install InfrAegis’ iaMedium, a kiosk that purportedly could detect the presence of nuclear or biological weapons, throughout the city and the agreement would result in profits of more than $80 million a year, the indictment alleges. While InfrAegis engaged in some discussions with the city about the installation of iaMediums in 2007 and 2008, there was never any agreement or contract to install the system in Chicago, documents said. In 2009 and 2010, Webb and InfrAegis allegedly falsely represented that the company had a contract with the Washington Metropolitan Area Transit Authority to install iaMediums throughout the Washington, D.C., Metro train system. Again, there was never any agreement or contract beyond initial negotiations, which were terminated when WMATA determined that InfrAegis was not financially responsible, documents said. The indictment alleges that Webb and InfrAegis concealed material facts from prospective and existing investors by failing to disclose that in 2007 and again in 2008, the Illinois secretary of state’s securities department issued orders prohibiting Webb and InfrAegis from selling securities in or from Illinois until further order. Those orders were not lifted until June 2010, when Webb and InfrAegis entered into an agreement with the state requiring them to comply with state securities laws in the offer and sale of securities.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

InfrAegis Patents

InfrAegis has filed 5 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/7/2012

3/25/2014

Foodborne illnesses, Food safety, Microbiology, Plant physiology, Molecular biology

Grant

Application Date

9/7/2012

Grant Date

3/25/2014

Title

Related Topics

Foodborne illnesses, Food safety, Microbiology, Plant physiology, Molecular biology

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.